IP
SRTA

Intellectus Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Intellectus Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Sell
115,450
-28,600
-20% -$150K 0.11% 188
2026
Q1 		$602K Sell
144,050
-3,500
-2% -$16.8K 0.12% 179
2025
Q4 		$710K Sell
147,550
-18,000
-11% -$87.1K 0.14% 163
2025
Q3 		$838K Sell
165,550
-11,000
-6% -$48.6K 0.16% 153
2025
Q2 		$711K Sell
176,550
-28,500
-14% -$92.8K 0.15% 165
2025
Q1 		$560K Sell
205,050
-1,000
-0.5% -$3.59K 0.14% 181
2024
Q4 		$876K Buy
206,050
+16,350
+9% +$62.2K 0.19% 142
2024
Q3 		$558K Sell
189,700
-7,850
-4% -$25K 0.14% 178
2024
Q2 		$687K Sell
197,550
-18,300
-8% -$61K 0.19% 148
2024
Q1 		$615K Buy
215,850
+1,500
+0.7% +$4.63K 0.16% 166
2023
Q4 		$757K Sell
214,350
-23,025
-10% -$66.1K 0.22% 127
2023
Q3 		$615K Buy
237,375
+3,250
+1% +$11.4K 0.19% 147
2023
Q2 		$922K Buy
234,125
+14,750
+7% +$46.8K 0.28% 103
2023
Q1 		$741K Buy
219,375
+36,600
+20% +$149K 0.23% 123
2022
Q4 		$654K Buy
182,775
+17,210
+10% +$73.5K 0.23% 132
2022
Q3 		$667K Buy
165,565
+3,350
+2% +$17.2K 0.24% 119
2022
Q2 		$723K Buy
+162,215
New +$1.17M 0.25% 112
2022
Q1 		– Sell
-174,125
Closed -$1.54M – 237
2021
Q4 		$1.54M Sell
174,125
-18,250
-9% -$173K 0.39% 63
2021
Q3 		$2M Buy
192,375
+22,800
+13% +$199K 0.48% 51
2021
Q2 		$1.78M Buy
+169,575
New +$1.67M 0.4% 61
2021
Q1 		– Sell
-92,500
Closed -$1.02M – 244
2020
Q4 		$1.02M Buy
+92,500
New +$944K 0.31% 100

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intellectus Partners's SRTA Position: Q2 2026 in Review

Intellectus Partners reduced its Strata Critical Medical Inc (SRTA) stake by 20% in Q2 2026, selling an estimated $150K and leaving 115,450 shares worth $608K. The position accounts for 0.11% of the portfolio, ranked #188.

Intellectus Partners first reported a position in SRTA in Q4 2020 and has held it in 21 quarters since. The position peaked at $2M in Q3 2021. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Intellectus Partners held 115,450 shares of Strata Critical Medical Inc worth $608K as of Q2 2026.
  • Intellectus Partners sold 28,600 Strata Critical Medical Inc shares in Q2 2026, an estimated $150K.
  • Strata Critical Medical Inc made up 0.11% of Intellectus Partners's portfolio in Q2 2026, its #188 holding.
  • Intellectus Partners first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 21 quarters since.
  • Intellectus Partners's Strata Critical Medical Inc position peaked at $2M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.